Conley Chee
Chief Executive Officer at SYROS PHARMACEUTICALS, INC.
Net worth: 120 396 $ as of 2024-03-30
Profile
Conley Chee is currently the President & Chief Executive Officer at Syros Pharmaceuticals, Inc. He previously worked at Novartis Pharmaceuticals as the Global Head-Portfolio Management.
Mr. Chee completed his undergraduate degree at the University of Alberta and holds an MBA from the Richard Ivey School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-31 | 22,504 ( 0.09% ) | 120 396 $ | 2024-03-30 |
Conley Chee active positions
| Companies | Position | Start |
|---|---|---|
| SYROS PHARMACEUTICALS, INC. | Chief Executive Officer | 2023-12-01 |
Former positions of Conley Chee
| Companies | Position | End |
|---|---|---|
Novartis Pharmaceuticals
 Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals is a German company that manufactures pharmaceutical products. The private company is based in Basel, Germany. | Corporate Officer/Principal | - |
Training of Conley Chee
| University of Alberta | Undergraduate Degree |
| Richard Ivey School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SYROS PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Novartis Pharmaceuticals
Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals is a German company that manufactures pharmaceutical products. The private company is based in Basel, Germany. | Health Technology |
- Stock Market
- Insiders
- Conley Chee
